Posts
-
Targeting Aberrant Learning May Improve Parkinson’s Treatment
Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the striatum may improve the efficacy of a first-line therapy for Parkinson’s disease and has the potential to reduce therapy-related side effects, according to a recent study published in Science Advances.
-
Shape-Shifting Cell Channel Reveals New Target for Precision Drugs
In a new study published in Nature Communications, Northwestern scientists have uncovered how a critical membrane pathway controls the flow of chemical messages responsible for everything from brain activity to inflammation.
-
2025 Year in Review
Feinberg experienced a year of discovery and scientific achievement in 2025, from honors and awards to unprecedented research discoveries.